These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
804 related articles for article (PubMed ID: 15234456)
1. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma. Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456 [TBL] [Abstract][Full Text] [Related]
2. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245 [TBL] [Abstract][Full Text] [Related]
3. Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy. Calabrese C; Pisi A; Di Febo G; Liguori G; Filippini G; Cervellera M; Righi V; Lucchi P; Mucci A; Schenetti L; Tonini V; Tosi MR; Tugnoli V Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1386-95. PubMed ID: 18559553 [TBL] [Abstract][Full Text] [Related]
4. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465 [TBL] [Abstract][Full Text] [Related]
5. [In vivo proton MR spectroscopy of normal liver parenchyma: technique and results]. Müller C; Hübner F; Bisdas S; Herzog C; Hammerstingl RM; Ackermann H; Vorbuchner M; Vogl TJ Rofo; 2006 Nov; 178(11):1128-36. PubMed ID: 17128381 [TBL] [Abstract][Full Text] [Related]
6. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309 [TBL] [Abstract][Full Text] [Related]
7. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. Bezabeh T; Smith IC; Krupnik E; Somorjai RL; Kitchen DG; Bernstein CN; Pettigrew NM; Bird RP; Lewin KJ; Briere KM Anticancer Res; 1996; 16(3B):1553-8. PubMed ID: 8694525 [TBL] [Abstract][Full Text] [Related]
9. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model. van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131 [TBL] [Abstract][Full Text] [Related]
10. [Proton MRS in a case of intracerebellar epidermoid]. Isobe T; Matsumura A; Anno I; Yoshizawa T; Itai Y; Nose T No To Shinkei; 2002 Feb; 54(2):163-6. PubMed ID: 11889764 [TBL] [Abstract][Full Text] [Related]
11. In vivo 1H MR spectroscopy of thyroid carcinoma. King AD; Yeung DK; Ahuja AT; Tse GM; Chan AB; Lam SS; van Hasselt AC Eur J Radiol; 2005 Apr; 54(1):112-7. PubMed ID: 15797300 [TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics and information on possible sites of interaction of intramyocellular metabolites in vivo from resolved dipolar couplings in localized 1H NMR spectra. Schröder L; Schmitz C; Bachert P J Magn Reson; 2004 Dec; 171(2):213-24. PubMed ID: 15546747 [TBL] [Abstract][Full Text] [Related]
13. Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo. Jordan BF; Black K; Robey IF; Runquist M; Powis G; Gillies RJ NMR Biomed; 2005 Nov; 18(7):430-9. PubMed ID: 16206237 [TBL] [Abstract][Full Text] [Related]
14. Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue. De Silva SS; Payne GS; Thomas V; Carter PG; Ind TE; deSouza NM NMR Biomed; 2009 Feb; 22(2):191-8. PubMed ID: 18833545 [TBL] [Abstract][Full Text] [Related]
15. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla. Booth SJ; Pickles MD; Turnbull LW BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962 [TBL] [Abstract][Full Text] [Related]
16. Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study. Chernov MF; Nakaya K; Kasuya H; Kato K; Ono Y; Yoshida S; Nakamura R; Suzuki T; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K J Neurol Sci; 2009 Sep; 284(1-2):168-74. PubMed ID: 19497588 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla. Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417 [TBL] [Abstract][Full Text] [Related]
18. In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. Bourne RM; Stanwell P; Stretch JR; Scolyer RA; Thompson JF; Mountford CE; Lean CL Eur J Radiol; 2005 Mar; 53(3):506-13. PubMed ID: 15741026 [TBL] [Abstract][Full Text] [Related]